Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 820 results for "daiichi sankyo company"

FDA to Review New Narcotic Analgesic Combo for Pain
Monthly Prescribing Reference

Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announc...

JUPITER, Fla. and PARSIPPANY, N.J., June 13, 2016 /PRNewswire/ -- Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ... Bloomberg, 2 weeks ago
New and Generic Drug Approvals: Benicar U.S. Food and Drug Administration, 2 weeks ago
FDA to Review New Narcotic Analgesic Combo for Pain Monthly Prescribing Reference, 2 weeks ago
[x]  

8 images for daiichi sankyo company

Reuters India, 4 weeks ago
Business Insider, 4 weeks ago
Channel NewsAsia, 4 weeks ago
Reuters India, 1 month ago
Yahoo! India, 1 month ago
Yahoo! India, 1 month ago
Stock Nod, 3 months ago
StatNews.com, 1 month ago
Money Control

Daiichi Sankyo Launches New Generic Drugs Through Its Daiichi Sankyo Espha Subsidiary

Release date- 16062016 - Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that on June 17, 2016, its generics subsidiary, Daiichi Sankyo Espha, will launch eleven new generic drugs with four new active ...
 Pharmacy Choice2 weeks ago Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer NSCLC  Pharmacy Choice2 weeks ago DAIICHI SANKYO : Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer NSCLC  4 Traders3 weeks ago Daiichi Sankyo Halts Late-Stage Trial for Lung Cancer Candidate  FDA News3 weeks ago
[x]  

DAIICHI SANKYO : Japan Research Foundation for Clinical Pharmacology 9th Annual Clinical Pharmacology Research Award

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders1 week ago 2016 Japan Pharma Outlook - growth drivers of 12 major Japanese biopharma companies  Before It's News1 week ago Five researchers win Japan Research Foundation for Clinical Pharmacology Research Award  PharmaBiz1 week ago

Daiichi Sankyo webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference

Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation TOKYO, June 13, 2016 /PRNewswire/ -- Daiichi Sankyo Co., Ltd (JP: 4568.T, OTC Pink:DSNKY) based in Tokyo, and focused on pharmaceutical ...
 Nasdaq2 weeks ago Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016  BioSpace3 weeks ago DAIICHI SANKYO : to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016  4 Traders3 weeks ago
[x]  

BRIEF-Daiichi Sankyo plans 28 mln shares repurchase

June 20 Daiichi Sankyo Co Ltd : * Says it plans to buy 28 million shares (4.1 percent outstanding) back, for up to 500 million yen, from June 21 to Oct. 28 Source text in Chinese: goo.gl/NPLZMI Further company coverage: (Beijing ...
 Reuters UK1 week ago BRIEF-Daiichi Sankyo to buy back up to 50 bln yen of stock  Reuters UK1 week ago

Daiichi Sankyo to Present Findings From New Subgroup Analyses of Once-Daily LIXIANA®¼ (edoxaban) in NVAF and VTE at ACC's 65th Annual Scientific Session

Comments MUNICH, March 24, 2016 /PRNewswire/ -- Four abstracts highlight new subgroup analyses from the global phase 3 ENGAGE AF-TIMI 48 and Hokusai-VTE studies to be presented in oral and poster sessions Daiichi Sankyo Europe GmbH Group ...
 AndhraNews.net2 weeks ago

Servier to Market Daiichi Sankyo's Edoxa...

Servier Canada has agreed to market Daiichi Sankyo's edoxaban in Canada, in an agreement hinging upon approval of the oral, once-daily anticoagulant by the country's health agency. The value of the agreement was not disclosed. Daiichi Sankyo did ...
 Genetic Engineering News4 days ago Servier Canada enters into an agreement with Daiichi Sankyo for factor Xa Inhibitor Edoxaban  International Business Times4 days ago DAIICHI SANKYO : Enters Into Agreement with Servier Canada For Factor Xa Inhibitor Edoxaban  4 Traders5 days ago BRIEF-Daiichi Sankyo says entered into agreement with Servier Canada  Reuters UK4 days ago
[x]  
Zacks.com

VideoNektar Therapeutics VP talks to TPL about Daiichi Sankyo deal on Onzeald04-06-2016

CHICAGO: Dr Mary Tagliaferri, vice president of clinical development at Nektar Therapeutics (Nasdaq: NKTR) talks to the Pharma Letter about the company's recently announced deal with Daiichi Sankyo (TYO: 4568) on breast cancer drug Onzeald ...
 Pharma Letter3 weeks ago Nektar Licenses European Onzeald Rights ...  Genetic Engineering News4 weeks ago Nektar (NKTR) Inks Deal With Daiichi Sankyo for Onzeald  Zacks.com4 weeks ago
[x]  

DAIICHI SANKYO : 14th Takamine Memorial Daiichi Sankyo Prize Winner Announced

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders1 day ago DAIICHI SANKYO : FTSE Russell Corporation Selects Daiichi Sankyo for FTSE4Good Global Index  4 Traders2 days ago FTSE Russell Corporation Selects Daiichi Sankyo for FTSE4Good Global Index  FirstWord Pharma1 day ago

DAIICHI SANKYO : Announces Status Relating to Acquisition of Own Shares

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders1 day ago DAIICHI SANKYO : to Issue Share Options as Remuneration  4 Traders1 week ago DAIICHI SANKYO : Announces Determination of Matters Relating to Acquisition of Own Shares  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less